Literature DB >> 12013533

Genetic basis of human breast cancer metastasis.

M T Debies1, D R Welch.   

Abstract

Once cancer cells have spread and formed secondary masses, breast cancers are largely incurable even with state-of-the-art medicine. To improve diagnosis and therapy, better markers are needed to distinguish cells which have a high probability for causing clinically relevant, macroscopic metastases. In this review, we summarize the several genes that regulate breast cancer metastasis. Two categories of genes are presented--metastasis activator (ras, MEK1, mta1, proteinases, adhesion molecules, chemoattractants/receptors, autotaxin, PKC, S100A4, RhoC, osteopontin) and metastasis suppressor (Nm23, E-cadherin, TIMPs, KiSS1, Kai1, Maspin, MKK4, BRMS1). While the mechanisms of action for most of these genes are not fully elucidated, some clues are emerging and are presented.

Entities:  

Mesh:

Year:  2001        PMID: 12013533     DOI: 10.1023/a:1014739131690

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  92 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 2.  Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.

Authors:  A Raz; R Lotan
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  Are selectins involved in metastasis?

Authors:  T Krause; G A Turner
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

4.  Crystal structure of a beta-catenin/Tcf complex.

Authors:  T A Graham; C Weaver; F Mao; D Kimelman; W Xu
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

Review 5.  Nm23 and tumour metastasis: basic and translational advances.

Authors:  J M Freije; N J MacDonald; P S Steeg
Journal:  Biochem Soc Symp       Date:  1998

6.  Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.

Authors:  T Akimoto; S Kawabe; A Grothey; L Milas
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

Review 7.  Rho GTPases: signaling, migration, and invasion.

Authors:  A A Schmitz; E E Govek; B Böttner; L Van Aelst
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

8.  Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.

Authors:  K M Hajra; X Ji; E R Fearon
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

9.  Osteopontin expression in a group of lymph node negative breast cancer patients.

Authors:  A B Tuck; F P O'Malley; H Singhal; J F Harris; K S Tonkin; N Kerkvliet; Z Saad; G S Doig; A F Chambers
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

10.  Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.

Authors:  M A Chekmareva; M M Kadkhodaian; C M Hollowell; H Kim; B A Yoshida; H H Luu; W M Stadler; C W Rinker-Schaeffer
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

View more
  28 in total

Review 1.  Role of homeobox genes in normal mammary gland development and breast tumorigenesis.

Authors:  Hexin Chen; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation.

Authors:  Macarena Perán; Juan Antonio Marchal; Maria A García; Julian Kenyon; David Tosh
Journal:  Cell Oncol (Dordr)       Date:  2013-05-16       Impact factor: 6.730

3.  Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.

Authors:  Douglas R Hurst; Alka Mehta; Blake P Moore; Pushkar A Phadke; William J Meehan; Mary Ann Accavitti; Lalita A Shevde; James E Hopper; Yi Xie; Danny R Welch; Rajeev S Samant
Journal:  Biochem Biophys Res Commun       Date:  2006-08-10       Impact factor: 3.575

Review 4.  Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.

Authors:  Johan Vad-Nielsen; Anders Lade Nielsen
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Suppression of Ras-stimulated transformation by the JNK signal transduction pathway.

Authors:  Norman J Kennedy; Hayla K Sluss; Stephen N Jones; Dafna Bar-Sagi; Richard A Flavell; Roger J Davis
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

6.  Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.

Authors:  Xiao-Yong Zhang; Lauren M DeSalle; Jagruti H Patel; Anthony J Capobianco; Duonan Yu; Andrei Thomas-Tikhonenko; Steven B McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

7.  Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.

Authors:  Daniel L Baker; Yuko Fujiwara; Kathryn R Pigg; Ryoko Tsukahara; Susumu Kobayashi; Hiromu Murofushi; Ayako Uchiyama; Kimiko Murakami-Murofushi; Eunjin Koh; Russell W Bandle; Hoe-Sup Byun; Robert Bittman; Dominic Fan; Mandi Murph; Gordon B Mills; Gabor Tigyi
Journal:  J Biol Chem       Date:  2006-06-16       Impact factor: 5.157

8.  KAI1 gene expression in colonic carcinoma and its clinical significances.

Authors:  De-Hua Wu; Li Liu; Long-Hua Chen; Yan-Qing Ding
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

9.  Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Authors:  Pankaj Taneja; Dejan Maglic; Fumitake Kai; Sinan Zhu; Robert D Kendig; Elizabeth A Fry; Kazushi Inoue
Journal:  Clin Med Insights Oncol       Date:  2010-04-20

10.  Role of JNK in a Trp53-dependent mouse model of breast cancer.

Authors:  Cristina Cellurale; Claire R Weston; Judith Reilly; David S Garlick; D Joseph Jerry; Hayla K Sluss; Roger J Davis
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.